This is an instance when both the median OS and HR fail to adequately capture the efficacy and one needs to look at the curves in full. L+P has an OS Benefit which diminishes over time.

Recently published online (early access) in Clinical Trials. Grateful to co-editors of Special Issue on Dose Optimization, especially Peter Thall, whose good humor & wit made the work more enjoyable. Stay tuned for full issue! #doseoptimization SCTorg
pubmed.ncbi.nlm.nih.gov/38570906/

Hello from Ankara, Turkey! 🇹🇷 Join ASCO member Yüksel Ürün for a #DayInTheLife of a medical oncologist as he cares for patients, conducts clinical research, provides mentorship, and more.

How to start a PhD

Kevin Mitchell Chill dude. I'm sure they know what they are doing.

Join biostatician Dr. Andrew Vickers (Andrew Vickers) for an oral session about myths about #PSA and #prostatecancer screening at #AACR24 (@AACR) today at 2:31 PST. Learn more: bit.ly/4al0E3h

📢On 4/6 #MSKBiostats Kathy Panageas & Sammi Brown, Bin Zhu from National Cancer Institute & Alex Paynter from AACR will present at #AACR24 workshop “Analytic Resources and Applications for AACR Project GENIE BPC Clinico-genomic Data”

⭐️Joint work w/ Jessica Lavery Hannah Fuchs Karissa Whiting

Always read the Methods. Sound advice from Pedro T Ramirez

An article that might be of interest:

We used the Royston Parmar’s flexible parametric survival models* (in many cases a superior alternative to the Cox model) to predict the survival of newborns with congenital heart defects.

*as implemented in Stata

susy.mdpi.com/publication/ar…

.Jessica Lavery will showcase her dissertation work titled 🩺‘Assessing Heterogeneous Treatment Effects with Time-to-Event Outcomes’ on March 13, 2024 from 11:15 to 11:30 am in session 125. This is joint work with Yuanjia Wang, Yuan Chen, Kathy Panageas.

📢The ENAR 📊2024 Spring Meeting will be held from March 10-13 in Baltimore, MD. Our team members from #MSKBiostats will be presenting and chairing. Expand the thread to learn more about their talks and contribution.

Interested in a pre-conference workshop at #SCT2024 ?

Check out the offerings here:

sctweb.org/meeting/#progr…

Voting for SCT positions is now open!

📊MAGPIE uses the assumption of mutual exclusivity of driver mutations🧬in oncogenic pathways🔀 to compute the probability of a gene being a driver & identifies important variants within candidate drivers
🎉Congrats to the team Ronglai Shen Colin Begg Caroline Kostrzewa & Alli Reiner

📜Check out the paper here: sciencedirect.com/science/articl…

🎉🥳Congrats to Dr. Xinjun Wang from #MSKBiostats for his work on a new statistical method📉 for identifying 🪛driver mutations, called MAGPIE (mutual exclusivity analysis of cancer-associated genes and variants and their probability of being a driver). #cancer Memorial Sloan Kettering Cancer Center

...

Very sadly, we have learned of the death of Professor Peter Armitage, CBE. Peter, who worked in a forerunner of the Unit 1947-1961, was a pioneer in developing statistical methodology for medical research. Our annual Armitage Lecture began in 2003 to honour this special man.

🚨Calling all applicants! MSK's Bridge to Biostats Summer Program is accepting applications for high school students!

❓ Questions? Attend our info session this Thursday at 5pm via zoom!
🔗To apply: admissions.mskcc.org/portal/apply-a…
📝More details in our flyer

🚨📢 Reminder to apply for the 2024 OPTICS (Oncology-focused Postdoctoral Training In Care delivery and symptom Science) fellowship program at
Memorial Sloan Kettering Cancer Center

📅 Deadline extended to this Friday, February 16

#CancerResearch #Oncology #MSKBiostats